COPD is a serious respiratory disease with an increasing incidence and mortality worldwide. Public awareness of COPD is low compared with other common diseases such as cerebrovascular disease, cancer and diabetes. At present, the focus of prevention and treatment of chronic obstructive pulmonary disease (COPD) is to take measures to further delay the decline of lung function and progression of the disease, and improve the quality of life of patients. The management and treatment of COPD in stable stage in modern medicine are still being explored and perfected.And the results of clinical research and systematic evaluation have shown that TCM treatment significantly improves the clinical symptoms, quality of life and exercise tolerance of patients with COPD on the whole. Especially in the stable treatment process, Chinese medicine shows great potential and is well tolerated for long-term use. For the comprehensive diagnosis and treatment of COPD, the clinical symptoms of the patient, the risk of acute exacerbation and the severity of lung function need to be comprehensively considered. The goal of treatment is to reduce the risk of disease by controlling symptoms, improving the quality of life and preventing and reducing acute exacerbations. In conclusion, TCM treatment plays an important role in patients with COPD, in that it can effectively improve the symptoms and quality of life, and shows the potential to prevent acute exacerbation. The combination of traditional Chinese medicine and modern medicine will be an important choice for the treatment of COPD.

Lingyan Jin, Dehai Yu, Hongxia Zhao, Haiyong Zhang. Research Progress of Traditional Chinese Medicine and Western Medicine in Stable Phase of Chronic Obstructive Pulmonary Disease. Academic Journal of Medicine & Health Sciences (2023) Vol. 4, Issue 8: 81-90. https://doi.org/10.25236/AJMHS.2023.040814.

[1] Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Global Strategy For Prevention, Diagnosis And Management Of Copd: 2023 Report [EB/OL]. https://goldcopd. org/2023-gold-report-2/

[2] Shanyan Wu, Lu G, Li-Meiz, et al. Effect of non-invasive ventilator in the Treatment of Chronic Obstructive Pulmonary Disease Controlled with Respiratory Failure [J]. Foreign Language Version: Medicine and Health, 2022(3):4. 

[3] Youjun L I , Zengfeng H , Chun F .Combined Traditional Chinese and Western Medicine Treatment of 60 Cases of Chronic Obstructive Pulmonary Disease in Stable Phase with Lung-Spleen Deficiency Type[J].Liaoning Journal of Traditional Chinese Medicine, 2014.

[4] Expert Group on Implementation Specifications for Clinical Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease. Implementation Specifications for Clinical Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease [J]. International Journal of Respiratory Medicine, 2022, 42 (6): 9. 

[5] Wang Hongyue, Gao Jian, Yang Fangjie et al. Application effect of nasal high flow humidified oxygen therapy in patients with chronic obstructive pulmonary disease and its influence on TNF-α and IL-6 levels [J]. Chinese Journal of Coal Industry Medicine, 2022, 25(02):216-220. 

[6] Wei Hongmei. Clinical effects and pulmonary function improvement of acute exacerbation of COPD treated with budesonide and terbutaline [J]. Heilongjiang Science, 2022, 13(06):128-129. 

[7] Li Jiansheng. International TCM Clinical Practice Guide for Chronic obstructive pulmonary disease [J]. World Chinese Medicine, 2020, 15(07):1084-1092. 

[8] Li Ning. Clinical efficacy of TCM specific therapies for chronic obstructive pulmonary disease in stable phase: a Meta-analysis [D]. Henan University of Traditional Chinese Medicine, 2017. 

[9] Ana F A, Loreto M S, María Isabel, Orts-Cortés, et al. Comparative analysis of the psychometric parameters of two quality-of-life questionnaires, the SGRQ and CAT, in the assessment of patients with COPD exacerbations during hospitalization: A multicenter study [J]. Chronic respiratory disease, 2019, 2018, Vol. 15, No. 4: 374-383. 

[10] Ito S, Araya J, Kurita Y, et al. PARK2-mediated mitophagy is involved in regulation of HBEC senescence in COPD pathogenesis [J]. Autophagy, 2015, 11(3):547-559. 

[11] Jun Y .Effect of Traditional Chinese Medicine Nursing for the patients in Stable phase of Chronic Obstructive Pulmonary Disease[J].Contemporary Medical Symposium, 2017.

[12] Chen Rui, Sun Ying, Liu Zailing. An applied study of 6-minute walk test for lung function [J]. Journal of Inner Mongolia Medical University, 2019, 41(S1):98-100. 

[13] Ren Y P, Shi R, Ray, Wang Qian, Li Cen, Lu Dandan, Zhao K X. A Meta-analysis of the efficacy and safety of tiotropium bromide in the treatment of chronic obstructive pulmonary disease [J]. China Pharmacy, 2015, 000(021):2947-2949. 

[14] Cheng-Cheng S U , Yan-Fen T , Yun Z .Efficacy evaluation of therapy of integrated traditional Chinese and western medicine for stable phase of chronic obstructive pulmonary disease[J].Shanxi Journal of Traditional Chinese Medicine, 2016.

[15] Kerwin E M, D'Urzo A D, Gelb A F, et al. Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I)[J] . COPD Journal of Chronic Obstructive Pulmonary Disease, 2012, 9(2):90-101. 

[16] Pierachille, Santus, Dejan, et al. Faster reduction in hyperinflation and improvement in lung ventilation inhomogeneity promoted by aclidinium compared to glycopyrronium in severe stable COPD patients. A randomized crossover study [J]. Pulmonary Pharmacology & Therapeutics, 2015. 

[17] Dushyant, Lal, Sachin, et al. Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease. [J]. Journal of Basic & Clinical Physiology & Pharmacology, 2015. 

[18] Wilairat P, Kengkla K, Thayawiwat C, et al. Clinical outcomes of theophylline use as add-on therapy in patients with chronic obstructive pulmonary disease: A propensity score matching analysis [J]. Chronic Respiratory Disease, 2019, 16. 

[19] Zhang Xiaofang, Cui Miaoling. Research progress of inhaled glucocorticoids in the treatment of COPD [J]. Nursing Research, 2019 (6): 4. 

[20] Bo Q U , Wei Z , Bing M .Cross-sectional Study on the Relationship between Syndromes of Traditional Chinese Medicine and Lung Function in Patients with Chronic Obstructive Pulmonary Disease at Stable Phase[J].West China Medical Journal, 2015.

[21] Calverley P M A, Anderson J A, Brook R D, et al. Fluticasone Furoate, Vilanterol and Lung Function Decline in Patients with Moderate COPD and Heightened Cardiovascular Risk. [J]. Am J Respir Crit Care Med, 2017, 197(1). 

[22] Hala, S, Abdel, et al. Montelukast versus Dexamethasone Treatment in a Guinea Pig Model of Chronic Pulmonary Neutrophilic Inflammation: COPD: Journal of Chronic Obstruc tive Pulmonary Disease: Vol 13, No 4[J]. Copd Journal of Chronic Obstructive Pulmonary Disease, 2015. 

[23] Wang Mei, Chen Xianhai. Chronic obstructive pulmonary disease and lung distension [J]. Henan Chinese Medicine, 2019, 39 (6): 3. DOI: 10. 16367/J. ISSN. 1003-5028. 2019. 06. 0207. 

[24] Li Jiansheng, Yu Xueqing, Xie Yang. International Practice Guide for Traditional Chinese Medicine chronic obstructive pulmonary disease [J]. World Chinese Medicine, 2020 (7): 1084-1092. 

[25] Yuan Changyou. Strategies and practices of research on treatment of chronic obstructive pulmonary disease by traditional Chinese medicine [J]. Electronic Journal of Cardiovascular Disease of Integrated Chinese and Western Medicine, 2016, 4 (19): 2. 

[26] Xia P , Sen H E , Feng Z ,et al.Research Progress of Treatment of Chronic Obstructive Pulmonary Disease from Qi[J].Journal of Liaoning University of Traditional Chinese Medicine, 2013. 

[27] Xue Xiaoming, Sun Yaoqin, Meng Lihong, et al. Meta-analysis of clinical efficacy of Chinese patent medicine in the treatment of chronic obstructive pulmonary disease in stable stage of lung and kidney deficiency [J]. Clinical Research of Traditional Chinese Medicine 2021, 13 (23), 129-136, 2021. 

[28] Shangjie B, Sha L, Xiaojun Lu. Effects of Yupingfeng Granules on Immune Function and Related Indexes of Children with Allergic Rhinitis Complicated with Bronchial Asthma [J]. China Pharmacy, 2018. 

[29] Feng Shuping, Wang Gefei, Chen Cui, et al. Effects of Yupingfeng Granule on pulmonary function, CAT score and immune function of patients in acute attack stage and subsequent stable stage of chronic obstructive pulmonary disease [J]. Modern journal of integrated traditional chinese and western medicine, 2020, 29 (36): 5. 

[30] Jiang Yike and Huang Guangping (eds). Clinical observation of Yupingfeng Powder in the treatment of stable chronic obstructive pulmonary disease (COPD) with lung-qi deficiency [J]. Chinese Journal of Modern Traditional Chinese Medicine, 2008, 004(004):297-299. 

[31] Lin Ganding, Xie Shangren. Clinical study of Yupingfeng Powder combined with Bufei Decoction in the treatment of chronic obstructive pulmonary disease in stable stage [J]. New traditional Chinese medicine, 2021. 

[32] Huazhi. Liujunzi. Decoction in the treatment of stable chronic obstructive pulmonary disease with lung and spleen deficiency syndrome and its effect on lung function and blood gas analysis [J]. Hebei Medical Science, 2018, 24 (12): 5. DOI: 10. 3969/J. ISSN. 1006-6233. 2018. 12. 042. 

[33] Yuebin W , Zhenhuai X .Clinical Observation of Integrated Traditional Medicine and Western Medicine in Treating Chronic Obstructive Pulmonary Disease at Acute Exacerbation Phase[J]. Research of Integrated Traditional Chinese and Western Medicine, 2013.

[34] Fan Yiling, Miao Qing, Liao Xing, Fan Changzheng, Fan Metaorong, Cao Qing, Wang Ning, Ma Qiuxiao, Hao Yani. A systematic review and meta-analysis of the efficacy and safety of Buzhong Yiqi Decoction in the treatment of chronic obstructive pulmonary disease at stable stage [J]. China Journal of Traditional Chinese Medicine, 2020, 45 (22): 12. 

[35] Hu Tao, Ma Jun, Cai Jingzhou, et al. Effects of Shenling Baizhu Powder on exercise tolerance and oxidative stress in patients with chronic obstructive pulmonary disease (COPD) at stable stage of lung and spleen deficiency [J]. Shi Zhen Guo Yi Guo Yao, 2019, 30 (1): 3. 

[36] QuJie, Fu Xuecong, Li Pei. Treatment of chronic obstructive pulmonary disease based on collateral disease phlegm and blood stasis obstructing collateral [J]. Liaoning journal of traditional chinese medicine, 2014, 41 (12): 2. 

[37] Kang Lingyu, Bai Zhengping, Liu Min, et al. Experience of Bai Zhengping in treating chronic obstructive pulmonary disease in stable stage from deficiency, phlegm and blood stasis [J]. Journal of Traditional Chinese Medicine, Hunan, 2016 (3): 2. 

[38] Li Fang, Wang Chuanbo, Wang Jieqiong, et al. Effects of Yiqi Huatan Huoxue Recipe on the protein expressions of Rock-1 and Rock-2 in lung tissue of rats with COPD phlegm-stagnation lung syndrome [J]. Shi Zhenguo Yi Guo Yao, 2015, 26 (4): 3. 

[39] Liu Guizhong, Zhang Kui. Effect of acupoint application with the method of benefiting qi, tonifying lung, activating blood and resolving phlegm on the quality of life of patients with stable COPD [J]. Chinese Journal of Science and Technology Database (full-text) Medicine and Health, 2022(1): 4. 

[40] Shan Meng, Huang Gang, Meng Li, et al. Clinical study of Yifei Huatan Huoxue Granules in the treatment of chronic obstructive pulmonary disease with qi deficiency and phlegm and blood stasis in stable stage [J]. Modern journal of integrated traditional chinese and western medicine, 2020, 29 (23): 5. 

[41] Zhu Xiaofeng. Effect of Yiqi Huoxue Huatan Decoction on lung function and blood gas index of patients with chronic obstructive pulmonary disease [J]. Clinical Research of Traditional Chinese Medicine, 2020, 12 (28): 3.